Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Carrageenan as an adjuvant to enhance peptide-based vaccine potency.

Zhang YQ, Tsai YC, Monie A, Hung CF, Wu TC.

Vaccine. 2010 Jul 19;28(32):5212-9. doi: 10.1016/j.vaccine.2010.05.068. Epub 2010 Jun 10.

PMID:
20541583
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

SA-4-1BBL as the immunomodulatory component of a HPV-16 E7 protein based vaccine shows robust therapeutic efficacy in a mouse cervical cancer model.

Sharma RK, Srivastava AK, Yolcu ES, MacLeod KJ, Schabowsky RH, Madireddi S, Shirwan H.

Vaccine. 2010 Aug 16;28(36):5794-802. doi: 10.1016/j.vaccine.2010.06.073. Epub 2010 Jul 4.

PMID:
20603135
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

DNA vaccines encoding IL-2 linked to HPV-16 E7 antigen generate enhanced E7-specific CTL responses and antitumor activity.

Lin CT, Tsai YC, He L, Yeh CN, Chang TC, Soong YK, Monie A, Hung CF, Lai CH.

Immunol Lett. 2007 Dec 15;114(2):86-93. Epub 2007 Oct 16.

PMID:
17976741
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Enhancement of protein vaccine potency by in vivo electroporation mediated intramuscular injection.

Kang TH, Monie A, Wu LS, Pang X, Hung CF, Wu TC.

Vaccine. 2011 Jan 29;29(5):1082-9. doi: 10.1016/j.vaccine.2010.11.063. Epub 2010 Dec 4.

PMID:
21130752
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Different domains of glycoprotein 96 influence HPV16 E7 DNA vaccine potency via electroporation mediated delivery in tumor mice model.

Daemi A, Bolhassani A, Rafati S, Zahedifard F, Hosseinzadeh S, Doustdari F.

Immunol Lett. 2012 Dec 17;148(2):117-25. doi: 10.1016/j.imlet.2012.10.003. Epub 2012 Oct 17.

PMID:
23085605
[PubMed - indexed for MEDLINE]
6.

Control of cervicovaginal HPV-16 E7-expressing tumors by the combination of therapeutic HPV vaccination and vascular disrupting agents.

Zeng Q, Peng S, Monie A, Yang M, Pang X, Hung CF, Wu TC.

Hum Gene Ther. 2011 Jul;22(7):809-19. doi: 10.1089/hum.2010.071. Epub 2011 Mar 9.

PMID:
21128743
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Improving therapeutic HPV peptide-based vaccine potency by enhancing CD4+ T help and dendritic cell activation.

Wu CY, Monie A, Pang X, Hung CF, Wu TC.

J Biomed Sci. 2010 Nov 22;17:88. doi: 10.1186/1423-0127-17-88.

PMID:
21092195
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Treatment with imiquimod enhances antitumor immunity induced by therapeutic HPV DNA vaccination.

Chuang CM, Monie A, Hung CF, Wu TC.

J Biomed Sci. 2010 Apr 28;17:32. doi: 10.1186/1423-0127-17-32.

PMID:
20426849
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Cluster intradermal DNA vaccination rapidly induces E7-specific CD8+ T-cell immune responses leading to therapeutic antitumor effects.

Peng S, Trimble C, Alvarez RD, Huh WK, Lin Z, Monie A, Hung CF, Wu TC.

Gene Ther. 2008 Aug;15(16):1156-66. doi: 10.1038/gt.2008.53. Epub 2008 Apr 10.

PMID:
18401437
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Histone deacetylase inhibitor AR-42 enhances E7-specific CD8⁺ T cell-mediated antitumor immunity induced by therapeutic HPV DNA vaccination.

Lee SY, Huang Z, Kang TH, Soong RS, Knoff J, Axenfeld E, Wang C, Alvarez RD, Chen CS, Hung CF, Wu TC.

J Mol Med (Berl). 2013 Oct;91(10):1221-31. doi: 10.1007/s00109-013-1054-9. Epub 2013 May 29.

PMID:
23715898
[PubMed - indexed for MEDLINE]
11.

Flagellin enhances tumor-specific CD8⁺ T cell immune responses through TLR5 stimulation in a therapeutic cancer vaccine model.

Nguyen CT, Hong SH, Sin JI, Vu HV, Jeong K, Cho KO, Uematsu S, Akira S, Lee SE, Rhee JH.

Vaccine. 2013 Aug 20;31(37):3879-87. doi: 10.1016/j.vaccine.2013.06.054. Epub 2013 Jul 2.

PMID:
23831323
[PubMed - indexed for MEDLINE]
12.

Enhanced anti-tumor effects of HPV16E7(49-57)-based vaccine by combined immunization with poly(I:C) and oxygen-regulated protein 150.

Chen S, Ou R, Tang J, Deng X, Wu Y, van Velkinburgh JC, Ni B, Xu Y.

Cancer Epidemiol. 2013 Apr;37(2):172-8. doi: 10.1016/j.canep.2012.10.005. Epub 2012 Nov 3.

PMID:
23127963
[PubMed - indexed for MEDLINE]
13.

Intratumoral injection of therapeutic HPV vaccinia vaccine following cisplatin enhances HPV-specific antitumor effects.

Lee SY, Kang TH, Knoff J, Huang Z, Soong RS, Alvarez RD, Hung CF, Wu TC.

Cancer Immunol Immunother. 2013 Jul;62(7):1175-85. doi: 10.1007/s00262-013-1421-y. Epub 2013 Apr 25.

PMID:
23615841
[PubMed - indexed for MEDLINE]
Free PMC Article
14.
15.

Heat shock protein 110 improves the antitumor effects of the cytotoxic T lymphocyte epitope E7(49-57) in mice.

Ren F, Xu Y, Mao L, Ou R, Ding Z, Zhang X, Tang J, Li B, Jia Z, Tian Z, Ni B, Wu Y.

Cancer Biol Ther. 2010 Jan;9(2):134-41. Epub 2010 Jan 21.

PMID:
19901562
[PubMed - indexed for MEDLINE]
Free Article
16.

TriVax-HPV: an improved peptide-based therapeutic vaccination strategy against human papillomavirus-induced cancers.

Barrios K, Celis E.

Cancer Immunol Immunother. 2012 Aug;61(8):1307-17. doi: 10.1007/s00262-012-1259-8. Epub 2012 Apr 22. Review.

PMID:
22527249
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

DNA vaccine with α-galactosylceramide at prime phase enhances anti-tumor immunity after boosting with antigen-expressing dendritic cells.

Kim D, Hung CF, Wu TC, Park YM.

Vaccine. 2010 Oct 21;28(45):7297-305. doi: 10.1016/j.vaccine.2010.08.079. Epub 2010 Sep 17.

PMID:
20817010
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.

Seo SH, Jin HT, Park SH, Youn JI, Sung YC.

Vaccine. 2009 Sep 25;27(42):5906-12. doi: 10.1016/j.vaccine.2009.07.033. Epub 2009 Aug 3.

PMID:
19651174
[PubMed - indexed for MEDLINE]
19.

Prophylactic and therapeutic efficacy of an attenuated Listeria monocytogenes-based vaccine delivering HPV16 E7 in a mouse model.

Jia Y, Yin Y, Duan F, Fu H, Hu M, Gao Y, Pan Z, Jiao X.

Int J Mol Med. 2012 Dec;30(6):1335-42. doi: 10.3892/ijmm.2012.1136. Epub 2012 Sep 20.

PMID:
23027427
[PubMed - indexed for MEDLINE]
20.

Long-lasting immunoprotective and therapeutic effects of a hyperstable E7 oligomer based vaccine in a murine human papillomavirus tumor model.

Cerutti ML, Alonso LG, Tatti S, de Prat-Gay G.

Int J Cancer. 2012 Apr 15;130(8):1813-20. doi: 10.1002/ijc.26294. Epub 2011 Aug 24.

PMID:
21780110
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk